Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

This report describes the pharmacokinetics of colistin methanesulfonate (CMS) and colistin in five intensive care unit patients receiving continuous venovenous hemodiafiltration. For CMS, the mean maximum concentration of drug in plasma (C(max)) after the fourth dose was 6.92 mg/liter and total clea...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Karvanen, Matti, Plachouras, Diamantis, Friberg, Lena E., Paramythiotou, Elisabeth, Papadomichelakis, Evangelos, Karaiskos, Ilias, Tsangaris, Iraklis, Armaganidis, Apostolos, Cars, Otto, Giamarellou, Helen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2013
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535942/
https://ncbi.nlm.nih.gov/pubmed/23147733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00985-12
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia